The Pharma Data

OCTOBER 19, 2020

is pleased to announce approval from Health Canada to proceed to a Phase 1 clinical trial with its lead asset, a long-acting anesthetic formulation for the treatment of post-surgical pain. TORONTO , Oct. 20, 2020 /PRNewswire/ – AmacaThera Inc.

Clinical Trials 40

Clinical Trials Clinical Trials Trials Life Science 40

The Pharma Data

DECEMBER 8, 2020

In addition, we have six Phase 3 trials underway, initiated 13 Phase 2 trials, achieved multiple, positive clinical proof-of-concept readouts, and advanced new delivery platforms.” The agreement provides Ionis the flexibility to reinvest resources to support its other commercial plans. Oral Delivery Development Update.

Medicine 52

Medicine RNA Production Marketing 52

pharmaphorum

DECEMBER 9, 2021

A true advocate for diversity and inclusion, she also sits on the EMEA Leadership Team for Johnson & Johnson’s LGBT+ employee resource group. In addition to her day-to-day work, Heather leads Inspire and Grow, a cross-sector learning initiative, and sits on the EMEA Leadership Team for JnJ’s LGBT+ employee resource group.

Allergies 105

Allergies Life Science Development Scientist 105

pharmaphorum

DECEMBER 15, 2020

Value-added versions of traditional medicines are one such way of innovating around existing molecules and, crucially, providing a better experience for patients through exploring new indications, changes to dosage or an improved formulation. Delivery of essential medicines. Ensuring healthcare sustainability.

Medicine 92

Medicine Production Manufacturing Life Science 92

pharmaphorum

AUGUST 10, 2020

While great progress has been made in diseases like diabetes, where HbA1c can be controlled for the majority of patients, we can still improve health outcomes further by providing better monitoring of disease and through more personalised drug delivery. Beyond capability, patients also need the opportunity to perform the planned behaviour.

Genetics 124

Genetics Drug Delivery Research Pharma Companies 124

The Pharma Data

MARCH 13, 2021

Commercialized ten new formulations and more than 430 new hybrids and varieties across corn, soybeans, cotton and vegetables. We have a long history of converting R&D into viable solutions for farmers that enhance productivity, add value and more efficiently use natural resources to produce a crop.”.

Production 40

Production Development Marketing Gene Editing 40

Drug Discovery World

FEBRUARY 14, 2024

Recent advances The past few years have seen considerable advances in vaccine R&D, addressing the drawbacks of conventional experimental approaches, and exploring advanced adjuvants and delivery systems that improve vaccine efficacy and accessibility 1.

Protein 59

Protein Vaccination Vaccine Manufacturing 59

The Pharma Data

AUGUST 3, 2021

Accelerates development of current Sanofi licensed programs in vaccines and potential to explore other therapeutic areas Fast tracks establishment of Sanofi’s recently announced mRNA Center of Excellence Full integration upgrades drug formulation capabilities and enhances US talent in a promising new technology. Morgan Stanley & Co.

Vaccination 52

Vaccination Vaccine Development Clinical Trials 52

Pharmaceutical Technology

SEPTEMBER 23, 2022

These companies often have limited in-house resources for product development or scale-up, and so depend on CDMO partnerships to achieve development milestones. Avéma’s team of scientists and manufacturing experts have more than 40 years of Rx formulation development expertise and decades of producing.

Manufacturing 147

Manufacturing Drugs Production Packaging 147

The Pharma Data

APRIL 27, 2021

At Pfizer, we apply science and our global resources to bring therapies to people that extend and significantly improve their lives. Side effects can be reported to EudraVigilance or directly to BioNTech using email [email protected] , telephone +49 6131 9084 0, or via the website www.biontech.de.

Vaccination 52

Vaccination Vaccine Manufacturing Clinical Trials 52

The Pharma Data

DECEMBER 1, 2020

The delivery of the 40 million doses will occur throughout 2020 and 2021, in stages, to ensure an equitable allocation of vaccines across the geographies with executed contracts. the companies will take immediate action to begin the delivery of vaccine doses. in the coming days, with complete delivery fulfilment expected in 2021.

Vaccination 40

Vaccination Vaccine Manufacturing Clinical Trials 40

Pharmaceutical Technology

OCTOBER 25, 2022

In addition, FDCs can be used to develop abuse deterrent formulations (ADFs). The goal of combination drug treatment is not only the delivery of two or more therapeutic agents that have different mechanisms of action. Companies can save valuable time and resources as well by taking advantage of the FDA’s 505(b)(2) approval pathway.

Manufacturing 130

Manufacturing Production Packaging Packaging 130

XTalks

MAY 13, 2022

Environmental conditions can affect product shelf life and the viability of product formulations. Drop testing: ensures the integrity of the packaging system through controlled drops or shocks, which may happen through the course of storage, shipment and delivery. Hence the new chamber can save on costs and resources.

Packaging 98

Packaging Packaging Containment Production 98

The Pharma Data

JULY 21, 2021

Pfizer and Biovac have worked together since 2015 on the sterile formulation, fill, finish and distribution of the Prevenar 13 vaccine. At Pfizer, we apply science and our global resources to bring therapies to people that extend and significantly improve their lives. About Pfizer: Breakthroughs That Change Patients’ Lives.

Manufacturing 52

Manufacturing Vaccination Vaccine Clinical Trials 52

The Pharma Data

JANUARY 15, 2021

Food and Drug Administration (FDA) approval of Darzalex Faspro ® (daratumumab and hyaluronidase-fihj), a subcutaneous formulation of daratumumab, in combination with bortezomib, cyclophosphamide and dexamethasone (D-VCd) for the treatment of adult patients with newly diagnosed light chain (AL) amyloidosis.[1]

FDA Approval 52

FDA Approval Production Research Doctors 52

The Pharma Data

MAY 7, 2021

Following the successful delivery of more than 170 million doses to the U.S. At Pfizer, we apply science and our global resources to bring therapies to people that extend and significantly improve their lives. CEO and Co-founder of BioNTech. About Pfizer: Breakthroughs That Change Patients’ Lives.

Licensing 52

Licensing Licensing Vaccination Vaccine 52

Drug Discovery World

AUGUST 3, 2023

11 The Cannabis Scientist’s Power List 2022 A resource which spotlights the research being undertaken regarding cannabis is The Cannabis Scientist’s Power List 2022, which has been compiled annually since its inception in 2020 12. deletion syndrome.

Medicine 52

Medicine Scientist Production Regulation 52

The Pharma Data

NOVEMBER 20, 2020

Manufacturing and Delivery Capabilities. At Pfizer, we apply science and our global resources to bring therapies to people that extend and significantly improve their lives. The BNT162b2 vaccine candidate is not currently approved for distribution anywhere in the world. About Pfizer: Breakthroughs That Change Patients’ Lives.

Vaccination 52

Vaccination Vaccine Clinical Trials Clinical Trials 52

The Pharma Data

MAY 6, 2021

Delivery of initial doses to participating delegations is expected to begin at the end of May where possible with the aim to ensure participating delegations receive second doses ahead of arrivals in Tokyo. At Pfizer, we apply science and our global resources to bring therapies to people that extend and significantly improve their lives.

Vaccination 52

Vaccination Vaccine Clinical Trials Clinical Trials 52

The Pharma Data

DECEMBER 11, 2020

immediately, with delivery fulfillment expected to be completed in 2021. Manufacturing and Delivery Capabilities. At Pfizer, we apply science and our global resources to bring therapies to people that extend and significantly improve their lives. With the vaccine being authorized for emergency use in the U.S.,

Vaccination 52

Vaccination Vaccine Clinical Trials Clinical Trials 52

Drug Discovery World

NOVEMBER 13, 2023

On Day 3, Thursday 16 November 2023, the tracks include: the second part of machine learning for protein engineering, antibodies against membrane protein targets, engineering bispecific antibodies, next-generation immunotherapies, protein stability and formulation, and protein process development.

Protein 59

Protein Antibody Engineer Scientist 59

The Pharma Data

DECEMBER 10, 2020

At Pfizer, we apply science and our global resources to bring therapies to people that extend and significantly improve their lives. The study also will explore prevention of infection by SARS-CoV-2, the virus that causes COVID-19. About Pfizer: Breakthroughs That Change Patients’ Lives.

Vaccination 52

Vaccination Vaccine Trials Medicine 52

The Pharma Data

NOVEMBER 9, 2020

At Pfizer, we apply science and our global resources to bring therapies to people that extend and significantly improve their lives. Pfizer and BioNTech plan to submit data from the full Phase 3 trial for scientific peer-review publication. About Pfizer: Breakthroughs That Change Patients’ Lives.

Vaccination 40

Vaccination Vaccine Clinical Trials Clinical Trials 40

Pfizer

JULY 26, 2022

The formulations of the Pfizer-BioNTech COVID-19 Vaccine authorized for use in individuals 6 months through 4 years of age, 5 through 11 years of age, and 12 years of age and older are different and should therefore not be used interchangeably. EUA Fact Sheet for Vaccination Providers (12 years of age and older), DO NOT DILUTE, Gray Cap.

Vaccination 111

Vaccination Vaccine Protein Immune Response 111

Pfizer

JULY 8, 2022

The formulations of the Pfizer-BioNTech COVID-19 Vaccine authorized for use in individuals 6 months through 4 years of age, 5 through 11 years of age, and 12 years of age and older are different and should therefore not be used interchangeably. About Pfizer: Breakthroughs That Change Patients’ Lives.

Vaccination 81

Vaccination Vaccine Clinical Trials Clinical Trials 81

Pfizer

JULY 19, 2022

The formulation of the Pfizer-BioNTech COVID-19 Vaccine authorized for use in individuals 6 months through 4 years of age, 5 through 11 years of age, and 12 years of age and older are different and should therefore not be used interchangeably. About Pfizer: Breakthroughs That Change Patients’ Lives.

Vaccination 100

Vaccination Vaccine Medicine Clinical Trials 100

The Pharma Data

JANUARY 25, 2021

Nasdaq: MTP), an R&D biotechnology company focused on improving the bio-delivery and biodistribution of medicines, announces a number of updates: 1. Optimised formulations have been developed for the two internal pipeline programmes, MTD211 and MTD219, with the former undergoing and the latter shortly to beginin vivostudies.

Containment 52

Containment Drug Delivery Licensing Licensing 52

Pfizer

SEPTEMBER 16, 2022

Standard marketing authorization recommendation applies to all indications and formulations in the European Union, including COMIRNATY® Original/Omicron BA.4-5 At Pfizer, we apply science and our global resources to bring therapies to people that extend and significantly improve their lives. Friday, September 16, 2022 - 08:00am.

Marketing 75

Marketing Vaccination Vaccine Clinical Trials 75

Pfizer

SEPTEMBER 28, 2022

At Pfizer, we apply science and our global resources to bring therapies to people that extend and significantly improve their lives. About Pfizer: Breakthroughs That Change Patients’ Lives.

Vaccination 101

Vaccination Vaccine Medicine Clinical Trials 101

Pfizer

OCTOBER 19, 2022

At Pfizer, we apply science and our global resources to bring therapies to people that extend and significantly improve their lives. 5), DO NOT DILUTE, Gray Cap EUA Fact Sheet for Vaccination Providers (5 through 11 Years), BIVALENT (Original and Omicron BA.4/BA.5), About Pfizer: Breakthroughs That Change Patients’ Lives.

Vaccination 40

Vaccination Vaccine Clinical Trials Clinical Trials 40

The Pharma Data

DECEMBER 18, 2020

The arrangements announced today will enable all participating economies to have access to doses in the first half of 2021, with first deliveries anticipated to begin in the first quarter of 2021 – contingent upon regulatory approvals and countries’ readiness for delivery. First deliveries in Q1 2021.

Vaccination 52

Vaccination Vaccine Manufacturing Development 52

Druggist

JULY 27, 2020

Some drugs need to be kept in their original packaging due to (physiochemical) properties of the formulation. ’ Common formulations in this category include soluble, effervescent and dispersible tablets, for example, aspirin 75mg , prednisolone soluble tablets, Madopar dispersible tablets. Can you put any drug in dosette boxes?

Pharmacy 69

Pharmacy Medicine Containment Packaging 69

Druggist

SEPTEMBER 7, 2020

There are plenty of online resources, including NHS and Mind websites which offer some excellent tips on improving your sleep. Two sedative antihistamines used in the formulation of sleeping pills in the UK are diphenhydramine and promethazine. Maximum recommended duration of the treatment is seven days. Buy on Amazon Price incl.

Containment 94

Containment Pharmacy Licensing Licensing 94

Pfizer

JULY 8, 2022

At Pfizer, we apply science and our global resources to bring therapies to people that extend and significantly improve their lives. About Pfizer: Breakthroughs That Change Patients’ Lives.

FDA Approval 102

FDA Approval Vaccination Vaccine Clinical Trials 102

XTalks

OCTOBER 1, 2020

Xtalks spoke with WeiQi Lin, MD, PhD, executive vice president, research & development, and principal scientist at DURECT Corporation — a company focused on developing drugs and drug delivery methods in therapeutic areas with significant unmet need — about her transition from academia to industry.

Scientist 52

Scientist In-Vitro Research Life Science 52

The Pharma Data

SEPTEMBER 15, 2020

Pipeline contributes to the Company’s expectation of at least 6% revenue CAGR over the next five years – and delivery of longer-term topline growth beyond that period. At Pfizer, we apply science and our global resources to bring therapies to people that extend and significantly improve their lives.

Gene Therapy 52

Gene Therapy Vaccination Vaccine Trials 52

Pfizer

NOVEMBER 2, 2022

At Pfizer, we apply science and our global resources to bring therapies to people that extend and significantly improve their lives. 5), DO NOT DILUTE, Gray Cap EUA Fact Sheet for Vaccination Providers (5 through 11 Years), BIVALENT (Original and Omicron BA.4/BA.5), About Pfizer: Breakthroughs That Change Patients’ Lives.

Vaccination 85

Vaccination Vaccine Clinical Trials Clinical Trials 85